Related Experiment Video

Updated: Aug 15, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients

James P Corsetti1, Wojciech Zareba, Arthur J Moss

  • 1Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Atherosclerosis
|October 26, 2005
PubMed

Insights

High C-reactive protein (CRP) and total cholesterol identify high-risk patients after heart attack. Among these, elevated high-density lipoprotein (HDL) predicts recurrent coronary events, highlighting complex cardiovascular risk factors.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Lipid Metabolism

Background:

  • Inflammation plays a key role in atherosclerosis development.
  • Interactions between inflammation and traditional lipoprotein risk factors are not well understood.
  • Investigating these interactions is crucial for understanding cardiovascular risk.

Purpose of the Study:

  • To investigate the interactions of inflammation and hyperlipidemia in generating cardiovascular risk.
  • To identify high-risk subgroups for recurrent coronary events in postinfarction patients.
  • To explore the predictive value of various blood markers within identified subgroups.

Main Methods:

  • Exploratory three-dimensional graphical screening of 767 non-diabetic postinfarction patients.
  • Utilized factor analysis-derived inflammatory and lipoprotein-related factors.
  • Kaplan-Meier and Cox multivariate analyses for risk confirmation and prediction.

Main Results:

  • A high-risk subgroup was identified, characterized by high C-reactive protein (CRP) and total cholesterol.
  • Cox analysis within this subgroup revealed elevated high-density lipoprotein (HDL) as a significant independent predictor of recurrent coronary events (HR, 2.24).
  • Metabolic, inflammatory, and thrombogenic markers were assessed, with only elevated HDL showing predictive value.

Conclusions:

  • Elevated high-density lipoprotein (HDL) predicts recurrent coronary events in non-diabetic postinfarction patients.
  • This prediction is specific to a subgroup with simultaneous elevations in serum CRP and total cholesterol.
  • Understanding these complex interactions is vital for refining cardiovascular risk assessment.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...